Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-26

Clinical Trial Update: Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update compares two formulations of oxcarbazepine for the treatment of bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Collaborative Care Initiative, LLC | Conditions: Bipolar Depression, Treatment Effectiveness | Phase 4 | Status: UNKNOWN